Related Experiment Video
Updated: Jul 27, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Propofol Regulates HIF-1 α Effect of Expression of Targeted SIRT1 Signal pathway on Kidney Renal Clear Cell Carcinoma
Xiaomei Chen1, Chongyi Li1, Rui Zeng1
1Department of Anesthesiology, Fuzhou Second Hospital, Fuzhou, 350007, Fujian Province, China. qulin68316373@163.com.
Abstract:
The objective of this study was to investigate the effect of propofol on kidney renal clear cell carcinoma (KIRC) by regulating hypoxia-inducible factor-1α (HIF-1α) expression and silencing signal regulatory factor 1 (SIRT1) signal pathway. In this regard, human KIRC cell line RCC4 was added into 0, 5 and 10 μ G/ml propofol treatment and was divided into a control group (CG), low dose group (LG) and high dose group (HG). CCK8 was used to detect the proliferative ability of the three groups of cells, ELISA was used to detect the level of inflammatory factors in the cells, Western blot was used to detect the protein expression, qPCR was used to detect the related mRNA expression level, and Transwell method was used to detect the invasive ability of the cells in vitro. The experimental results showed that propofol decreased the proliferation and invasion ability of KIRC cells, up-regulated the expression of TGF- β 1, IL-6, TNF- α, HIF-1 α, Fas, bax and FasL, and down-regulated the expression of SIRT1 in a dose-dependent manner. It was concluded that propofol can inhibit the SIRT1 signal pathway by up-regulating the level of HIF-1α in KIRC, which can significantly decrease the proliferation and invasion ability of KIRC cells, induce apoptosis and increase the release of intracellular inflammatory factors.
Insights
Propofol inhibits kidney cancer progression by downregulating SIRT1 and upregulating HIF-1α. This reduces cancer cell proliferation and invasion, inducing apoptosis and increasing inflammatory factors.
Area of Science:
- Oncology
- Anesthesiology
- Molecular Biology
Background:
- Kidney renal clear cell carcinoma (KIRC) is a significant health concern.
- The roles of hypoxia-inducible factor-1α (HIF-1α) and SIRT1 in KIRC are not fully understood.
- Propofol's potential anti-cancer effects warrant investigation.
Purpose of the Study:
- To investigate propofol's effect on KIRC.
- To explore propofol's regulation of HIF-1α and the SIRT1 pathway in KIRC.
- To determine propofol's impact on KIRC cell proliferation, invasion, and apoptosis.
Main Methods:
- Utilized human KIRC cell line (RCC4) with varying propofol concentrations (0, 5, 10 μg/ml).
- Assessed cell proliferation using CCK8 assay.
- Measured inflammatory factors via ELISA.
- Analyzed protein and mRNA expression using Western blot and qPCR.
- Evaluated cell invasion in vitro using Transwell assays.
Main Results:
- Propofol dose-dependently decreased KIRC cell proliferation and invasion.
- Propofol upregulated TGF-β1, IL-6, TNF-α, HIF-1α, Fas, Bax, and FasL.
- Propofol downregulated SIRT1 expression.
Conclusions:
- Propofol inhibits KIRC progression by upregulating HIF-1α and downregulating SIRT1.
- Propofol treatment reduces KIRC cell proliferation and invasion.
- Propofol induces apoptosis and increases intracellular inflammatory factors in KIRC cells.
More Related Videos
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
09:17Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...